DOK

DOCUSATE SODIUM ORAL HUMAN OTC DRUG

DOK is an FDA drug label for the active ingredient DOCUSATE SODIUM manufactured by MAJOR PHARMACEUTICALS administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231023.

Generic name
DOCUSATE SODIUM
Manufacturer
MAJOR PHARMACEUTICALS
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
0904-6750
Application
M007
Label effective
20231023

Active ingredients

Active ingredient Docusate Sodium 100 mg

Indications & Usage

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours

Dosage & Administration

Directions do not exceed recommended dose adults and children 12 years and older: take 1-3 tablets daily, or as directed by a doctor. May be taken as a single daily dose or in divided doses. children under 12: consult a doctor

Contraindications

Not available.

Warnings

Warnings Ask a doctor before use if you have stomach pain, nausea or vomiting have a sudden change in bowel habits that persists over a period of 2 weeks are presently taking mineral oil Stop use and ask a doctor if you need to use a laxative longer than 1 week you have rectal bleeding or fail to have a bowel movement. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use.

Adverse Reactions

Not available.

More products with the same ingredient

DOCUSATE SODIUM

Docusate Sodium

A-S Medication Solutions View label

Docusate Sodium

Asclemed USA, Inc. View label

Stool Softener

Allegiant Health View label

Stool Softener

Allegiant Health View label

Stool Softener

KROGER COMPANY View label

Stool Softener

Geri-Care Pharmaceutical Corp View label

Stool Softener

Geri-Care Pharmaceutical Corp View label